Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Agilent Technologies Inc. (A)

77.95   -2.55 (-3.17%) 02-25 16:03
Open: 80.7 Pre. Close: 80.5
High: 80.88 Low: 77.69
Volume: 2,585,545 Market Cap: 24164M
Agilent Technologies Inc is engaged in life sciences, diagnostics and applied chemical markets. The company provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 80.927 - 81.433 81.433 - 81.789
Low: 76.517 - 77.139 77.139 - 77.578
Close: 77.097 - 78.003 78.003 - 78.642

Technical analysis

as of: 2020-02-25 4:26:50 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 100.09     One year: 105.87
Support: Support1: 77.70    Support2: 64.65
Resistance: Resistance1: 85.70    Resistance2: 90.64
Pivot: 84.04
Moving Average: MA(5): 82.63     MA(20): 84.21
MA(100): 81.36     MA(250): 77.02
MACD: MACD(12,26): -1.04     Signal(9): -0.42
Stochastic oscillator: %K(14,3): 28.33     %D(3): 45.13
RSI: RSI(14): 28.76
52-week: High: 90.64  Low: 65.35  Change(%): -1.9
Average Vol(K): 3-Month: 180601  10-Days: 236697

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
A has closed below the lower band by 24.0%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 58.6% wider than normal. The large width of the bands suggest high volatility as compared to A's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue.

Headline News

Arima Genomics schließt Serie-A-Finanzierung ab
SAN DIEGO, Kalifornien (USA)--(BUSINESS WIRE)--Arima Genomics, Inc., ein Unternehmen, das sich auf Forschungstools zur Verbesserung des Verständnisses der Genomsequenz und -struktur im Hinblick auf ihre Funktion für die menschlichen Gesundheit und das Entstehen von Krankheiten konzentriert, gibt den Abschluss seiner Serie-A-Finanzierungsrunde bekannt. Agilent Technologies, Inc. (NYSE: A) und Cowin Venture führten diese Runde an, der sich außerdem Vectr Ventures und der Berkeley Catalyst Fund an

Arima Genomics Completa la Financiación de la Serie A
SAN DIEGO--(BUSINESS WIRE)--Arima Genomics, Inc., una compañía focalizada en herramientas de investigación para acelerar la comprensión de la secuencia y de la estructura de los genomas y su función en la salud y en enfermedad humanas, anuncia que ha completado su ronda de financiación de la Serie A. Agilent Technologies, Inc. (NYSE: A) y Cowin Venture dirigieron esta ronda, junto con Vectr Ventures y Berkeley Catalyst Fund. “Agilent invierte en socios de la industria para promover el desarroll

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Diagnostics Research
Shares Out. (M) 309.00
Shares Float (M) 309.18
% Held by Insiders 0.37
% Held by Institutions 88.31
Shares Short (K) 4660
Shares Short P. Month (K)

Stock Financials

EPS 3.370
Book Value (p.s.) 15.360
PEG Ratio 2.73
Profit Margin 20.74
Operating Margin 20.20
Return on Assets (ttm) 7.3
Return on Equity (ttm) 23.0
Qtrly Rev. Growth 5.6
Gross Profit (p.s.) 9.094
Sales Per Share
EBITDA (p.s.) 4.142
Qtrly Earnings Growth -0.50
Operating Cash Flow (M) 1020.00
Levered Free Cash Flow (M) 846.63

Stock Valuations

P/E 23.12
P/E Growth Ratio -0.03
P/BV 5.07
P/S 4.73
P/CF 23.60

Dividends & Splits

Dividend 0.660
Dividend Yield 0.01
Dividend Pay Date 2020-01-21
Ex-Dividend Date 2019-12-29
Forward Dividend 0.720
Last Split Date 2014-11-02
Last Split Ratio -4.9
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.